We further confirmed the downregulation of SSP in advanced prostate cancer cell lines (Fig. 2A) and advanced prostate cancer patient-derived xenografts (PDXs) (Fig. 2B), which show the downregulation of PHGDH, the first and rate-limiting enzyme of SSP. The gene discussed is PHGDH; the disease is prostate carcinoma.